公司概覽
業務類別 Biotechnology
業務概覽 BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. Its key drug is Attruby (acoramidis), an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
公司地址 3160 Porter Drive, Suite 250, Palo Alto, CA, USA, 94304
電話號碼 +1 650 391-9740
傳真號碼 --
公司網頁 https://www.bridgebio.com
員工數量 839
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Neil Kumar, PhD Director; Chief Executive Officer of the Company and Eidos Therapeutics, Inc. 美元 1.04M 24/04/2026
Dr. Thomas Trimarchi, PhD President and Chief Financial Officer 美元 675.59K 24/04/2026
Ms. Maricel M. Apuli Chief Accounting Officer -- 24/02/2026
 
董事會成員
董事會 職務 更新日期
Dr. Charles J. Homcy,M.D. Lead director 24/04/2026
Mr. Fred Hassan Lead Independent Director 24/04/2026
Mr. James C. Momtazee Independent Director 24/04/2026
Dr. Frank P. McCormick, D.Sc.,F.R.S.,PhD Director 24/04/2026
Dr. Eric Aguiar, M.D. Independent Director 24/04/2026
Mr. Ali J. Satvat Independent Director 24/04/2026
Mr. Douglas A. Dachille Independent Director 24/04/2026
Dr. Neil Kumar, PhD Director; Chief Executive Officer of the Company and Eidos Therapeutics, Inc. 24/04/2026
Ms. Jennifer E. Cook Independent Director 24/04/2026
Mr. Ronald J. Daniels Independent Director 24/04/2026
Dr. Andrew W. Lo, PhD Independent Director 24/04/2026
Dr. Hannah A. Valantine, M.D. Independent Director 24/04/2026
Ms. Andrea John Ellis Independent Director 24/04/2026
 
所屬ETF (更新日期: 07/11/2026 03:53)
代號 名稱 佔比% ▼ 持有日期
SPXXNuveen S&P 500 Dynamic Overwrite0.0004%30/09/2026
AAUBAlpha Architect US Equity 4 ETF0.0004%31/07/2026
FEMGFidelity Enhanced Mid Cap Growth ETF0.0003%30/10/2026
SSMGVirtus Silvant Small/Mid Growth ETF0.0003%30/10/2026
PWSPacer WealthShield ETF0.0003%30/10/2026
STXGStrive 1000 Growth ETF0.0003%30/10/2026
PBSMInvesco PureBeta MSCI USA Small Cap ETF0.0002%31/05/2023
MFMOMotley Fool Momentum Factor ETF0.0002%30/10/2026
PCSGPolen 5Perspectives Small-Mid Growth ETF0.0001%30/09/2026
AVIEAvantis Inflation Focused Equity ETF0.0001%30/10/2026
FFFFounders 100 ETF0.0001%30/10/2026
SCDSJPMorgan Fundamental Data Sci Sm Cor ETF0.0001%30/10/2026
AVTMAvantis Total Equity Markets ETF0.0001%30/10/2026
BAYCorgi Bay Area Based ETF0.0001%30/10/2026
FESMFidelity Enhanced Small Cap Core ETF0.0001%31/07/2026
REVSColumbia Research Enhanced Value ETF0.00005%31/10/2026
REMCColumbia Research Enhanced Mid Cap ETF0.00004%31/10/2026
RADDAB US Research Advanced ETF0.00003%30/10/2026
ONEOStt Strt® SPDR® Russell 1000 Momt FocETF0.00002%30/10/2026
AVUCAvantis U.S. Core Equity ET0.00001%30/10/2026
  1    2    3    4    5   6    7    8    9  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.